These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22595639)

  • 1. Development of a micro dosing system for fine powder using a vibrating capillary. Part 1: the investigation of factors influencing on the dosing performance.
    Chen X; Seyfang K; Steckel H
    Int J Pharm; 2012 Aug; 433(1-2):34-41. PubMed ID: 22595639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a micro-dosing system for fine powder using a vibrating capillary. Part 2. The implementation of a process analytical technology tool in a closed-loop dosing system.
    Chen X; Seyfang K; Steckel H
    Int J Pharm; 2012 Aug; 433(1-2):42-50. PubMed ID: 22564779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of a low-dose capsule filling process by dynamic and static tests for advanced process understanding.
    Stranzinger S; Faulhammer E; Scheibelhofer O; Calzolari V; Biserni S; Paudel A; Khinast JG
    Int J Pharm; 2018 Apr; 540(1-2):22-30. PubMed ID: 29407875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of material attributes and process parameters on the powder bed uniformity during a low-dose dosator capsule filling process.
    Stranzinger S; Faulhammer E; Calzolari V; Biserni S; Dreu R; Šibanc R; Paudel A; Khinast JG
    Int J Pharm; 2017 Jan; 516(1-2):9-20. PubMed ID: 27826028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low powder mass filling of dry powder inhalation formulations.
    Eskandar F; Lejeune M; Edge S
    Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blending of agglomerates into powders 1: Quantification of abrasion rate.
    Willemsz TA; Oostra W; Hooijmaijers R; de Vegt O; Morad N; Vromans H; Frijlink HW; Van der Voort Maarschalk K
    Int J Pharm; 2010 Mar; 387(1-2):87-92. PubMed ID: 20015470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entrainment of lactose inhalation powders: a study using laser diffraction.
    Watling CP; Elliott JA; Cameron RE
    Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow rate and flow equation of pharmaceutical free-flowable powder excipients.
    Sklubalová Z; Zatloukal Z
    Pharm Dev Technol; 2013 Feb; 18(1):106-11. PubMed ID: 22149908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H; Markefka P; teWierik H; Kammelar R
    Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: comparison with lactose carrier.
    Hassan MS; Lau R
    Int J Pharm; 2010 Feb; 386(1-2):6-14. PubMed ID: 19922775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    Le VN; Bierend H; Robins E; Steckel H; Flament MP
    Int J Pharm; 2012 Jan; 422(1-2):75-82. PubMed ID: 22036653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Nano Spray Dryer B-90 for pharmaceutical applications.
    Schmid K; Arpagaus C; Friess W
    Pharm Dev Technol; 2011 Aug; 16(4):287-94. PubMed ID: 20491538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
    Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the effects of high shear blending on lactose and drug using fluidised bed elutriation.
    Willetts JP; Robbins PT; Roche TC; Bowley M; Bridson RH
    Int J Pharm; 2012 Sep; 434(1-2):272-9. PubMed ID: 22683647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flowability characterisation of drug-excipient blends using a novel powder avalanching method.
    Nalluri VR; Kuentz M
    Eur J Pharm Biopharm; 2010 Feb; 74(2):388-96. PubMed ID: 19796683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscale granulation in a fluid bed powder processor using electrostatic atomisation.
    Kivikero N; Murtomaa M; Ingelbeen B; Antikainen O; Räsänen E; Mannermaa JP; Juppo AM
    Eur J Pharm Biopharm; 2009 Jan; 71(1):130-7. PubMed ID: 18703138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC; Podczeck F; Turnbull N
    Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.